ProPhase Labs, Inc.

PRPH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
NT 10-K Mar 18, 2024
8-K Mar 15, 2024
SC 13G/A Feb 14, 2024
8-K Jan 4, 2024
10-Q Nov 13, 2023 10-Q
8-K Nov 9, 2023
10-Q Aug 11, 2023 10-Q
8-K Aug 10, 2023
8-K Jun 29, 2023
4/A Jun 22, 2023
4/A Jun 22, 2023
4/A Jun 22, 2023
8-K Jun 22, 2023
4 Jun 21, 2023
4 Jun 21, 2023
4 Jun 21, 2023
8-K Jun 20, 2023
8-K Jun 20, 2023
10-Q May 12, 2023 10-Q
8-K May 11, 2023
ARS Apr 27, 2023
DEF 14A Apr 27, 2023
8-K Apr 25, 2023
4 Apr 6, 2023
8-K Apr 6, 2023
← Newer Page 6 of 36 · 884 filings Older →